ID24374A - Komposisi-komposisi parenteral alatrofloksasin - Google Patents

Komposisi-komposisi parenteral alatrofloksasin

Info

Publication number
ID24374A
ID24374A IDW20000200A ID20000200A ID24374A ID 24374 A ID24374 A ID 24374A ID W20000200 A IDW20000200 A ID W20000200A ID 20000200 A ID20000200 A ID 20000200A ID 24374 A ID24374 A ID 24374A
Authority
ID
Indonesia
Prior art keywords
alatrofloxasin
parenteral compositions
parenteral
compositions
Prior art date
Application number
IDW20000200A
Other languages
English (en)
Inventor
Robert Mark Guinn
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID24374A publication Critical patent/ID24374A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IDW20000200A 1997-08-01 1998-07-23 Komposisi-komposisi parenteral alatrofloksasin ID24374A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5424697P 1997-08-01 1997-08-01

Publications (1)

Publication Number Publication Date
ID24374A true ID24374A (id) 2000-07-13

Family

ID=21989735

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000200A ID24374A (id) 1997-08-01 1998-07-23 Komposisi-komposisi parenteral alatrofloksasin

Country Status (40)

Country Link
US (1) US6194429B1 (id)
EP (1) EP1000086B1 (id)
JP (1) JP3463928B2 (id)
KR (1) KR20010022495A (id)
CN (1) CN1265671A (id)
AP (1) AP1031A (id)
AR (1) AR015417A1 (id)
AT (1) ATE259827T1 (id)
AU (1) AU734863B2 (id)
BG (1) BG104105A (id)
BR (1) BR9811580A (id)
CA (1) CA2296466C (id)
CO (1) CO4970688A1 (id)
DE (1) DE69821767T2 (id)
DK (1) DK1000086T3 (id)
DZ (1) DZ2576A1 (id)
EA (1) EA002120B1 (id)
ES (1) ES2214716T3 (id)
GT (1) GT199800112A (id)
HN (1) HN1998000106A (id)
HR (1) HRP980417B1 (id)
HU (1) HUP0004793A3 (id)
ID (1) ID24374A (id)
IL (1) IL134156A0 (id)
IS (1) IS5339A (id)
MA (1) MA24626A1 (id)
NO (1) NO20000485L (id)
NZ (1) NZ502249A (id)
OA (1) OA11281A (id)
PA (1) PA8456701A1 (id)
PE (1) PE103799A1 (id)
PL (1) PL338477A1 (id)
PT (1) PT1000086E (id)
SK (1) SK1012000A3 (id)
TN (1) TNSN98146A1 (id)
TW (1) TW538043B (id)
UY (1) UY25113A1 (id)
WO (1) WO1999006430A1 (id)
YU (1) YU2500A (id)
ZA (1) ZA986874B (id)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2231275T3 (es) * 1999-10-08 2005-05-16 Affinium Pharmaceuticals, Inc. Inhibidores de fab i.
EP1121933A1 (en) * 2000-02-02 2001-08-08 Pfizer Products Inc. Premixed alatrofloxacin injectable compositions
JP4387804B2 (ja) * 2001-04-06 2009-12-24 アフィニアム・ファーマシューティカルズ・インコーポレイテッド ＦａｂＩ阻害剤
PT1575951E (pt) 2002-12-06 2014-09-15 Debiopharm Int Sa Compostos heterocíclicos, métodos para os preparar e sua utilização em terapia
EP1608377B1 (en) 2003-03-17 2008-10-01 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
US8450307B2 (en) * 2004-06-04 2013-05-28 Affinium Pharmaceuticals, Inc. Therapeutic agents, and methods of making and using the same
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
EP2054422B1 (en) 2006-07-20 2017-06-14 Debiopharm International SA Acrylamide derivatives as fab i inhibitors
WO2008098374A1 (en) * 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
EP2861608B8 (en) 2012-06-19 2019-06-19 Debiopharm International SA Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
AU2015249222A1 (en) * 2014-04-25 2016-11-17 Naurex, Inc. Stable compositions of neuroactive peptides
DK3419628T3 (da) 2016-02-26 2021-01-11 Debiopharm Int Sa Medikament til behandling af diabetiske fodinfektioner
EP3740494A4 (en) 2018-02-02 2021-11-03 Ripple Therapeutics Corporation GLASS FORMULATIONS WITH STEROID DIMERS AND USES THEREOF
WO2020154815A1 (en) 2019-02-01 2020-08-06 Ripple Therapeutics Corporation Crystalline forms of dexamethasone dimers and uses thereof
ES2944535T3 (es) 2019-02-14 2023-06-22 Debiopharm Int Sa Formulación de afabicina, método para preparar la misma
UA129222C2 (uk) 2019-06-14 2025-02-12 Дебіофарм Інтернешнл С.А. Лікарський засіб і його застосування для лікування бактеріальних інфекцій, пов'язаних з біоплівкою
US12509469B2 (en) 2019-08-07 2025-12-30 Ripple Therapeutics Corporation Compositions and methods for the treatment of pain and dependence disorders
CA3176134A1 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3713672A1 (de) 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
CZ286896B6 (en) 1994-01-18 2000-07-12 Pfizer Process for preparing pharmaceutically acceptable salts of naphthyridone carboxylic acid and intermediates for this preparation
TW420610B (en) 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5475116A (en) 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
DE69503066T2 (de) 1995-06-06 1998-10-15 Pfizer Inc., New York, N.Y. KRISTALLFORM VON WASSERFREIEN 7-((1a,5a,6a)-6-AMINO-3-AZABICYCLO (3.1.0.) HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDIN-CARBONSÄURE METHANESULFONSÄURE SALZ
DE69622715T2 (de) * 1995-06-15 2002-11-14 Pfizer Inc., New York Verfahren zur herstellung von derivaten der ein peptid enthaltenden azabizylo-naphtyridin-carbonsäure
US6080756A (en) 1995-08-29 2000-06-27 Pfizer Inc. Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin
TR199800339T1 (xx) 1995-08-29 1998-06-22 Pfizer Inc. Trovafloksasinin melez iyonik bi�imleri.
GB9524466D0 (en) 1995-11-30 1996-01-31 Pfizer Ltd Process
JPH1087617A (ja) 1996-07-09 1998-04-07 Pfizer Inc キノリン系抗生物質の合成に有用な中間体の製法

Also Published As

Publication number Publication date
JP2001512133A (ja) 2001-08-21
AU734863B2 (en) 2001-06-21
PE103799A1 (es) 1999-10-25
ES2214716T3 (es) 2004-09-16
HUP0004793A2 (hu) 2001-04-28
AU8236898A (en) 1999-02-22
AP9801310A0 (en) 1998-09-30
EP1000086A1 (en) 2000-05-17
BR9811580A (pt) 2000-08-22
DE69821767T2 (de) 2005-01-13
TNSN98146A1 (fr) 2005-03-15
PT1000086E (pt) 2004-05-31
IL134156A0 (en) 2001-04-30
KR20010022495A (ko) 2001-03-15
NO20000485D0 (no) 2000-01-31
EP1000086B1 (en) 2004-02-18
HRP980417A2 (en) 1999-08-31
PA8456701A1 (es) 2000-05-24
EA200000086A1 (ru) 2000-08-28
DK1000086T3 (da) 2004-05-17
SK1012000A3 (en) 2000-09-12
YU2500A (sh) 2002-09-19
UY25113A1 (es) 2000-12-29
MA24626A1 (fr) 1999-04-01
ATE259827T1 (de) 2004-03-15
BG104105A (bg) 2000-08-31
AP1031A (en) 2001-12-21
NZ502249A (en) 2001-11-30
AR015417A1 (es) 2001-05-02
IS5339A (is) 2000-01-14
CO4970688A1 (es) 2000-11-07
CA2296466A1 (en) 1999-02-11
HN1998000106A (es) 1999-01-08
WO1999006430A1 (en) 1999-02-11
CA2296466C (en) 2003-04-15
OA11281A (en) 2002-11-19
JP3463928B2 (ja) 2003-11-05
US6194429B1 (en) 2001-02-27
DZ2576A1 (fr) 2003-02-22
CN1265671A (zh) 2000-09-06
PL338477A1 (en) 2000-11-06
TW538043B (en) 2003-06-21
HRP980417B1 (en) 2002-10-31
ZA986874B (en) 2000-01-31
HUP0004793A3 (en) 2001-10-29
EA002120B1 (ru) 2001-12-24
DE69821767D1 (de) 2004-03-25
GT199800112A (es) 2000-01-15
NO20000485L (no) 2000-03-27

Similar Documents

Publication Publication Date Title
ID22931A (id) Komposisi-komposisi herbisidal
DK1298194T3 (da) Staniolholdige sammensætninger
ID16251A (id) Komposisi-komposisi pembasmi kuman
PT945132E (pt) Composicao de ibuprofeno
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
DE69832516D1 (de) Isoflavon-enthaltende zusammensetzungen
ID26549A (id) Komposisi-komposisi epotilon
ATE367793T1 (de) Schweisshemmende zusammensetzungen
FI974241A0 (fi) BPM-15 -koostumukset
DE69803761D1 (de) Schmierölzusammensetzungen
DE69919953D1 (de) Funktionelle zusammensetzungen
ATE469550T1 (de) Antiparasitäre zusammensetzungen
ID25508A (id) Komposisi dematologis
ID24458A (id) Modifikasi rheologi in-sito poliolefin
PT1014987E (pt) Composicoes orais de levosimendano
DE69927758D1 (de) Imidosilan-Zusammensetzungen
ATE209959T1 (de) Mikroverkapselte zusammensetzungen
ATE293672T1 (de) Farbschonende zusammensetzungen
DE69617029D1 (de) Organoton-zusammensetzungen
NO981568D0 (no) Randtennings-tennsatssammensetninger
DE69719442D1 (de) Frisierschaum-Zusammensetzungen
ID27889A (id) Komposisi-komposisi kopolimer polisiklik
MA24626A1 (fr) Compositions parenterales d'alatrofloxacine
NO984662L (no) Vann-i-olje-emulsjonsgj°dningsstoff-sammensetninger
DK0975348T3 (da) Stabiliserede tibolon-sammensætninger